about
Interleukin-10 inhibits elevated chemokine interleukin-8 and regulated on activation normal T cell expressed and secreted production in cystic fibrosis bronchial epithelial cells by targeting the I(k)B kinase alpha/beta complexNeutrophils in cystic fibrosis display a distinct gene expression patternGlucocorticoid receptor gene polymorphisms associated with progression of lung disease in young patients with cystic fibrosisCystic fibrosis transmembrane conductance regulator controls lung proteasomal degradation and nuclear factor-kappaB activity in conditions of oxidative stress.Airway epithelial cell inflammatory signalling in cystic fibrosis.Hyperinflammation in airways of cystic fibrosis patients: what's new?Macrolides: new therapeutic perspectives in lung diseases.Alveolar epithelial cells: master regulators of lung homeostasis.Lung disease modifier genes in cystic fibrosis.New insights about miRNAs in cystic fibrosis.Translating the genetics of cystic fibrosis to personalized medicine.Azithromycin analogue CSY0073 attenuates lung inflammation induced by LPS challenge.Glucocorticoids reduce inflammation in cystic fibrosis bronchial epithelial cells.Azithromycin fails to reduce inflammation in cystic fibrosis airway epithelial cells.Reduced expression of Tis7/IFRD1 protein in murine and human cystic fibrosis airway epithelial cell models homozygous for the F508del-CFTR mutation.Restoration of chloride efflux by azithromycin in airway epithelial cells of cystic fibrosis patients.Oxidative stress induces extracellular signal-regulated kinase 1/2 mitogen-activated protein kinase in cystic fibrosis lung epithelial cells: Potential mechanism for excessive IL-8 expression.Involvement of toll-like receptor 4 in the inflammatory reaction induced by hydroxyapatite particles.Intracellular colocalization and interaction of IGF-binding protein-2 with the cyclin-dependent kinase inhibitor p21CIP1/WAF1 during growth inhibitionCalcium-dependent regulation of NF-(kappa)B activation in cystic fibrosis airway epithelial cells.MicroRNA-9 downregulates the ANO1 chloride channel and contributes to cystic fibrosis lung pathology.Fluticasone reduces IL-6 and IL-8 production of cystic fibrosis bronchial epithelial cells via IKK-beta kinase pathway.Anoctamin 1 dysregulation alters bronchial epithelial repair in cystic fibrosis.Oxidative stress response results in increased p21WAF1/CIP1 degradation in cystic fibrosis lung epithelial cells.Reduction of chemokine IL-8 and RANTES expression in human bronchial epithelial cells by a sea-water derived saline through inhibited nuclear factor-kappaB activation.Enhanced F508del-CFTR channel activity ameliorates bone pathology in murine cystic fibrosis.Distinct cytokine production by lung and blood neutrophils from children with cystic fibrosisCirculating and airway neutrophils in cystic fibrosis display different TLR expression and responsiveness to interleukin-10Adherence of airway neutrophils and inflammatory response are increased in CF airway epithelial cell-neutrophil interactionsGap junctional communication does not contribute to the interaction between neutrophils and airway epithelial cellsMorphological analysis of the trachea and pattern of breathing in βENaC-Tg mice[Challenges of personalized medicine for cystic fibrosis]Cystic fibrosis bone disease: is the CFTR corrector C18 an option for therapy?Small RNA and transcriptome sequencing reveal the role of miR-199a-3p in inflammatory processes in cystic fibrosis airways
P50
Q35748847-49E462C7-A33C-4C66-84D9-5278F3CE8356Q36145489-4AC8D5BE-FEFC-4D11-B0E7-BF5FA5DFD04BQ36412679-105BFB54-CAD6-45D5-AA7A-096508A628ECQ36579774-CE64D994-4E69-47D2-9CB2-4C055AF23605Q37146884-367F8EE5-CE54-4533-A85B-E2CA7ECC1883Q37206228-483048E7-BD70-4F8C-8C3B-4719E3C8F7EBQ37884178-64378667-CBA0-4DAC-BCFA-579217EA2584Q38132525-F2C05E80-5016-4032-836F-7F58D362B7B4Q38191095-06B07B10-D543-43F6-9690-123D5C4C8C73Q38357780-572B832B-CB96-4391-BB5A-41210275FB59Q38458352-E4F0E320-D372-4706-9867-1D7B49912674Q38529613-AF3A34DA-BDA1-44B3-9DCE-85E1140DB0F0Q39404988-B8E23B5E-CDAB-4F4B-B682-B7542BD9A608Q39447569-AF12CC52-0C07-4658-A84E-230A013456B5Q39514115-1B326A36-0387-49DA-9598-742C54AF89E6Q39609645-C84FC7CA-CE5C-4041-9280-93A59987441FQ40067729-6101D317-F92B-4CE0-B8FD-E31380309328Q40283577-88CB7BD7-1469-4E49-B8FE-020EACD4DD30Q40379945-250D7201-8487-4036-A89A-87A05A970B71Q40387796-A4A71DBD-B7C9-4472-A11D-D5D40740480DQ42164308-1D7C5668-0337-4748-9984-F72E402D4C94Q44450521-1A5BAF63-D1B0-4F78-8BDF-5A138788E684Q46632563-260F2A9E-1CDB-4117-99C1-AC24974976EEQ46842795-8768A697-5250-430D-8385-B0C68733C955Q51656029-96AE05EC-6705-4F6E-B13F-D37681D3CA65Q51752980-B2E90DA0-1ECA-4FCB-B8C5-3A447DFFA8E0Q78840949-822D5005-3EF0-43D7-A112-8006DC9AFC2FQ80135119-06CDE120-3E74-42AF-8010-BD3D286B3143Q81446781-9D9E9DBE-29C0-44C1-B6BD-CC0986EE4084Q83153517-597B9431-80FB-4965-A3A8-BB503AC1D46CQ84432632-4B42FEC6-A1D7-4FE9-8C68-796D79044B6DQ85234050-543C4E61-BF45-4555-9BF5-67A0156F3BC0Q86073896-7FE81DDD-92C5-471B-B6E1-11CFE48E9C2EQ88585552-980E9821-87D6-41E0-A786-DB7F9D19A88E
P50
description
researcher
@en
wetenschapper
@nl
հետազոտող
@hy
name
Olivier Tabary
@ast
Olivier Tabary
@en
Olivier Tabary
@es
Olivier Tabary
@nl
type
label
Olivier Tabary
@ast
Olivier Tabary
@en
Olivier Tabary
@es
Olivier Tabary
@nl
prefLabel
Olivier Tabary
@ast
Olivier Tabary
@en
Olivier Tabary
@es
Olivier Tabary
@nl
P106
P31
P496
0000-0003-1997-2400